Early Invasive versus Conservative Strategies for Non-ST-Segment Elevation Acute Coronary Syndromes: A Review of Pivotal Randomized Trials

Abstract

Introduction: The optimal management of Non-ST-Segment Elevation Acute Coronary Syndromes (NSTE-ACS) has been a central question in cardiology, focusing on the timing of coronary angiography and revascularization. The debate centered on two approaches: a routine "early invasive" strategy versus a selective "conservative" strategy.

Literature Review: A review of pivotal randomized controlled trials that defined the modern approach to NSTE-ACS reveals a clear advantage for an early invasive strategy, particularly in patients at higher risk. Landmark trials, such as TACTICS-TIMI 18, demonstrated that a strategy involving routine early cardiac catheterization followed by revascularization significantly reduced the composite risk of death, myocardial infarction, or rehospitalization for an acute coronary syndrome compared to a conservative approach where intervention was reserved for failed medical therapy. While some trials yielded more neutral results, subsequent meta-analyses confirmed the overall benefit of the invasive approach, highlighting that the greatest advantage was seen in patients with high-risk features, such as elevated cardiac troponins. This body of evidence drove the development of risk stratification models as a key component of clinical decision-making.

Conclusion: The evidence reviewed established a risk-stratified approach as the standard of care for NSTE-ACS. For the majority of patients, particularly those at moderate-to-high risk, an early invasive strategy was proven to be superior in reducing ischemic events, fundamentally shaping contemporary clinical practice guidelines.